270
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Voriconazole Induced Ocular Surface Dysplasia – Report of Two Cases

, MD, FRCS Ed, , MD, , MD & , MD, FRCS Ed
Pages 210-214 | Received 24 Apr 2020, Accepted 09 Jun 2019, Published online: 13 Aug 2020
 

ABSTRACT

Purpose

To report ocular surface dysplasia induced by voriconazole treatment in two patients with recalcitrant fungal keratitis.

Methods

Observational study

Results

Case 1 – A 49 year old female who was a known case of fungal keratitis and treated with prolonged topical voriconazole therapy, underwent penetrating keratoplasty and the histopathological examination of corneal specimen showed multiple keratin pearls with dyskeratotic cells suggestive of squamous cell carcinoma.

Case 2 - A 78-year-old man who was diagnosed as fungal keratitis in his left eye and treated with topical voriconazole 1% and itraconazole 1% for 6 months underwent therapeutic penetrating keratoplasty. Histopathology of the host corneal tissue showed squamous cells with irregular thickening with dyskeratotic cells and squamous eddies suggestive of voriconazole induced dysplasia.

Conclusion

Prolonged topical voriconazole treatment in fungal keratitis can induce ocular surface dysplasia. Early diagnosis and treatment of the dysplastic changes can result in complete remission and prevent recurrence.

Declaration of interest

The authors report no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.